Chlamydia antigens and corresponding DNA fragments and uses thereof
AssigneeAventis Pasteur Limited
InventorsAndrew D. Murdin, Raymond P. Oomen, Pamela L. Dunn
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence encoding a CPN100605 polypeptide of a strain of Chlamydia pneumoniae and a promoter to effect expression of the CPN100605 polypeptide in the host. Modifications are possible within the scope of this invention.
Claims5
An isolated polypeptide from a strain of Chiamydia that has at least 90% identity to SEQ ID NO:4, wherein said isolated polypeptide, when administered in an immunogenically-effective amount to a mammal, induces an immune response by said mammal against said strain of Chiamydia.
Dependencies are inferred from the claim text.